Dr. Georgios Constantinou, MD

Dr. Constantinou practices at Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana.

Dr. Constantinou's NPI, 1790030278, was assigned on July 19, 2012. Dr. Constantinou holds Louisiana license 309978.

Dr. Constantinou's primary practice is Regional Eye Surgery Center - Baton Rouge, at 7777 Hennessey Blvd, Suite 5000, Baton Rouge, LA 70808. The practice phone is (225) 214-6688.

Dr. Constantinou's primary practice is Regional Eye Surgery Center - Baton Rouge in Baton Rouge, Louisiana. Dr. Constantinou is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Constantinou to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Constantinou practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Constantinou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Constantinou is licensed in Louisiana.

CMS data shows 222 Medicare services from Dr. Constantinou across 6 procedure codes in 2024, for 89 Medicare patients. Medicare paid $16,779 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Dr. Constantinou in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Constantinou's median patient age at 67, with 54% women.

In 2024, Dr. Constantinou wrote 996 Medicare Part D claims for 160 patients. 77% of them were for generic drugs. CMS names the drug for 609 of them, across 25 drugs with 11 or more claims each, at $595,686 in total drug cost. In 2023, CMS named 418 claims across 19 drugs.

Dr. Constantinou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Constantinou as offering telehealth.

CMS Open Payments shows 762 general payments to Dr. Constantinou from 69 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 92% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,514.